Literature DB >> 23759944

Neuronal mechanism of epileptogenesis in EL mouse.

Jiro Suzuki1.   

Abstract

The convulsions of the EL mouse (EL) were described by Imaizumi et al. in 1954 and were established as epilepsy by Suzuki in 1976. The EL mouse has been kept as an inbred strain and is considered one of the best animal models originated in Japan. The mode of inheritance is autosomal dominant, and environmental risk factors for seizure occurrence are hypothesised to contribute to the polygenic background. Paroxysmal activities in the EL brain arise from the parietal cortex (PCX) and are augmented in the hippocampus, demonstrated by electrophysiology and autoradiography using 2-deoxy glucose when clinical symptoms of seizures appeared. The neurons in the EL PCX, where GABA activity is lower than that of DDY PCX demonstrate increased excitability to proprioceptive sensory input. After repetitive seizure-provoking stimuli, seizures are more easily induced, eventually occurring spontaneously. This phenomenon of "abnormal plasticity" is also observed in the EEG, decreasing GABA activity, expression of the immediately early gene, and various biochemical and molecular processes. This phenomenon is similar to the learning or progressive process of certain neurological diseases.

Entities:  

Mesh:

Year:  2013        PMID: 23759944      PMCID: PMC3749469          DOI: 10.2183/pjab.89.270

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  22 in total

1.  Paroxysmal discharges in the electroencephalogram of the E1 mouse.

Authors:  J Suzuki
Journal:  Experientia       Date:  1976-03-15

2.  Temporal ontogeny of circuit activation prior to the onset of seizure susceptibility in EL/Suz mice.

Authors:  M P Leussis; S C Heinrichs
Journal:  Neuroscience       Date:  2007-01-04       Impact factor: 3.590

3.  Role of nitric oxide in the epileptogenesis of EL mice.

Authors:  Y L Murashima; M Yoshii; J Suzuki
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

4.  The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat.

Authors:  L Sokoloff; M Reivich; C Kennedy; M H Des Rosiers; C S Patlak; K D Pettigrew; O Sakurada; M Shinohara
Journal:  J Neurochem       Date:  1977-05       Impact factor: 5.372

5.  Environmental risk factors for multifactorial epilepsy in EL mice.

Authors:  M T Todorova; T J Burwell; T N Seyfried
Journal:  Epilepsia       Date:  1999-12       Impact factor: 5.864

6.  Abnormal plastic phenomena of sensory-precipitated epilepsy in the mutant El mouse.

Authors:  J Suzuki; Y Nakamoto
Journal:  Exp Neurol       Date:  1982-02       Impact factor: 5.330

7.  Seizure patterns and electroencephalograms of E1 mouse.

Authors:  J Suzuki; Y Nakamoto
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1977-09

8.  Metabolic studies on ep mouse, a special strain with convulsive predisposition.

Authors:  M Kurokawa; H Naruse; M Kato
Journal:  Prog Brain Res       Date:  1966       Impact factor: 2.453

9.  New therapeutic approaches for epilepsies, focusing on reorganization of the GABAA receptor subunits by neurosteroids.

Authors:  Yoshiya L Murashima; Mitsunobu Yoshii
Journal:  Epilepsia       Date:  2010-07       Impact factor: 5.864

10.  Developmental alteration in RNA metabolism of E1 mouse brain.

Authors:  S Yamagami; K Ohno; M Tsuji; K Mori; Y Kawakita
Journal:  Folia Psychiatr Neurol Jpn       Date:  1981
View more
  2 in total

Review 1.  Serotonin and sudden unexpected death in epilepsy.

Authors:  Alexandra N Petrucci; Katelyn G Joyal; Benton S Purnell; Gordon F Buchanan
Journal:  Exp Neurol       Date:  2019-12-19       Impact factor: 5.330

2.  Elevated Blood C-Reactive Protein Levels in Patients With Epilepsy: A Systematic Review and Meta-Analysis.

Authors:  Rui Zhong; Qingling Chen; Mengmeng Li; Xinyue Zhang; Weihong Lin
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.